BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 23001133)

  • 1. Non-genomic effect of glucocorticoids on cardiovascular system.
    Lee SR; Kim HK; Youm JB; Dizon LA; Song IS; Jeong SH; Seo DY; Ko KS; Rhee BD; Kim N; Han J
    Pflugers Arch; 2012 Dec; 464(6):549-59. PubMed ID: 23001133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why do we need nongenomic glucocorticoid mechanisms?
    Jiang CL; Liu L; Tasker JG
    Front Neuroendocrinol; 2014 Jan; 35(1):72-5. PubMed ID: 24103541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways.
    Sevilla LM; Jiménez-Panizo A; Alegre-Martí A; Estébanez-Perpiñá E; Caelles C; Pérez P
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
    Löwenberg M; Stahn C; Hommes DW; Buttgereit F
    Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptor signaling in the eye.
    Sulaiman RS; Kadmiel M; Cidlowski JA
    Steroids; 2018 May; 133():60-66. PubMed ID: 29129720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
    Dejager L; Vandevyver S; Petta I; Libert C
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and nongenomic effects of glucocorticoids.
    Stahn C; Buttgereit F
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nongenomic effects of glucocorticoids].
    Grzanka A; Jarzab J
    Pneumonol Alergol Pol; 2009; 77(4):387-93. PubMed ID: 19722144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nongenomic glucocorticoid effects and their mechanisms of action in vertebrates.
    Johnstone WM; Honeycutt JL; Deck CA; Borski RJ
    Int Rev Cell Mol Biol; 2019; 346():51-96. PubMed ID: 31122395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology.
    Sevilla LM; Pérez P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal triglyceride accumulation is regulated by mineralocorticoid receptor activation under basal and stress conditions.
    Faught E; Vijayan MM
    J Physiol; 2019 Oct; 597(19):4927-4941. PubMed ID: 31246274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Mechanisms of Glucocorticoids.
    Vandewalle J; Luypaert A; De Bosscher K; Libert C
    Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease.
    Cappetta D; Bereshchenko O; Cianflone E; Rossi F; Riccardi C; Torella D; Berrino L; Urbanek K; De Angelis A; Bruscoli S
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Glucocorticoid Receptor Actions in Bone Homeostasis and Bone Diseases.
    Lee S; Krüger BT; Ignatius A; Tuckermann J
    Front Endocrinol (Lausanne); 2021; 12():815386. PubMed ID: 35082759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-genomic Effects of Glucocorticoids: An Updated View.
    Panettieri RA; Schaafsma D; Amrani Y; Koziol-White C; Ostrom R; Tliba O
    Trends Pharmacol Sci; 2019 Jan; 40(1):38-49. PubMed ID: 30497693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.
    Ayroldi E; Macchiarulo A; Riccardi C
    FASEB J; 2014 Dec; 28(12):5055-70. PubMed ID: 25205742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways.
    Ayroldi E; Cannarile L; Migliorati G; Nocentini G; Delfino DV; Riccardi C
    FASEB J; 2012 Dec; 26(12):4805-20. PubMed ID: 22954589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic signaling pathways in rapid, nongenomic action of glucocorticoid.
    Chen YZ; Qiu J
    Mol Cell Biol Res Commun; 1999; 2(3):145-9. PubMed ID: 10662589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
    Vandevyver S; Dejager L; Tuckermann J; Libert C
    Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.